[go: up one dir, main page]

ZA200107976B - Low dose estrogen interrupted hormone replacement therapy. - Google Patents

Low dose estrogen interrupted hormone replacement therapy.

Info

Publication number
ZA200107976B
ZA200107976B ZA200107976A ZA200107976A ZA200107976B ZA 200107976 B ZA200107976 B ZA 200107976B ZA 200107976 A ZA200107976 A ZA 200107976A ZA 200107976 A ZA200107976 A ZA 200107976A ZA 200107976 B ZA200107976 B ZA 200107976B
Authority
ZA
South Africa
Prior art keywords
interrupted
low dose
replacement therapy
hormone replacement
dose estrogen
Prior art date
Application number
ZA200107976A
Other languages
English (en)
Inventor
Robert F Casper
Garry A Shangold
Militza K Ausmanas
Original Assignee
Jencap Res Ltd
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jencap Res Ltd, Ortho Mcneil Pharm Inc filed Critical Jencap Res Ltd
Publication of ZA200107976B publication Critical patent/ZA200107976B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200107976A 1999-03-30 2001-09-28 Low dose estrogen interrupted hormone replacement therapy. ZA200107976B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12697099P 1999-03-30 1999-03-30

Publications (1)

Publication Number Publication Date
ZA200107976B true ZA200107976B (en) 2004-11-24

Family

ID=22427647

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107976A ZA200107976B (en) 1999-03-30 2001-09-28 Low dose estrogen interrupted hormone replacement therapy.

Country Status (17)

Country Link
US (5) US6747019B2 (xx)
EP (1) EP1165183A1 (xx)
JP (1) JP2002541126A (xx)
KR (1) KR20010112386A (xx)
CN (1) CN1200747C (xx)
AR (1) AR029159A1 (xx)
AU (1) AU3412300A (xx)
CA (1) CA2267743C (xx)
CZ (1) CZ20013493A3 (xx)
HU (1) HUP0200416A3 (xx)
MX (1) MXPA01009813A (xx)
NZ (1) NZ514463A (xx)
PL (1) PL202043B1 (xx)
RU (1) RU2245713C2 (xx)
TR (1) TR200102860T2 (xx)
WO (1) WO2000059577A1 (xx)
ZA (1) ZA200107976B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
PT1482948E (pt) * 2002-03-11 2006-11-30 Janssen Pharmaceutica Nv Terapia de substituição hormonal contínua com progestogénio inibidor de sulfatase
WO2003082299A1 (en) * 2002-04-03 2003-10-09 Jencap Research Ltd. Improved hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
BR0313921A (pt) * 2002-08-28 2005-07-19 Gideon Kopernik Regime de reposição de estrogênio
EP1635843B1 (en) * 2003-06-25 2009-01-07 Bayer Schering Pharma Aktiengesellschaft Therapy comprising dienogest for hormone replacement and depression
WO2005030176A1 (en) * 2003-09-29 2005-04-07 Novo Nordisk Femcare Ag Improved stability of progestogen formulations
JP2007506796A (ja) * 2003-09-29 2007-03-22 ノボ・ノルディスク・フェムケア・アーゲー Ｈｒｔ製剤
RU2246249C1 (ru) * 2004-05-05 2005-02-20 Гальцова Наталья Евгеньевна Способ профилактики сердечно-сосудистых заболеваний у женщин в климактерическом периоде на фоне заместительной гормональной терапии
CA2569738A1 (en) * 2004-06-07 2005-12-22 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
WO2006013464A1 (en) * 2004-07-27 2006-02-09 Amistad Pharma Sas Hormone replacement therapy comprising a combination of 17-beta-oestradiol and chlormadinone acetate
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
EP1971325A2 (en) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
RU2428201C1 (ru) * 2010-07-28 2011-09-10 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ лечения начального рака эндометрия
WO2012142039A1 (en) * 2011-04-15 2012-10-18 University Of North Dakota Combination of liver x receptor modulator and estrogen receptor modulator for the treatment of age-related diseases
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015179782A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
MX2018011705A (es) 2016-04-01 2019-06-10 Therapeuticsmd Inc Composicion farmaceutica de hormona esteroide.
CN111035763A (zh) * 2018-10-13 2020-04-21 合肥医工医药有限公司 一种治疗妇女更年期综合症的药物组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
EP0303306B1 (en) 1987-08-08 1993-03-10 Akzo N.V. Contraceptive implant
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) * 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
EP0559240B1 (en) * 1987-09-24 2001-12-05 Jencap Research Limited Contraceptive packages containing oestrogen and progestin
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
US5897539A (en) * 1995-09-28 1999-04-27 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy

Also Published As

Publication number Publication date
AU3412300A (en) 2000-10-23
US20080182828A1 (en) 2008-07-31
CN1200747C (zh) 2005-05-11
TR200102860T2 (tr) 2002-02-21
EP1165183A1 (en) 2002-01-02
WO2000059577A1 (en) 2000-10-12
US20100063019A1 (en) 2010-03-11
JP2002541126A (ja) 2002-12-03
US6747019B2 (en) 2004-06-08
US7320970B2 (en) 2008-01-22
CA2267743A1 (en) 2000-09-30
US20040180867A1 (en) 2004-09-16
PL350854A1 (en) 2003-02-10
MXPA01009813A (es) 2003-05-02
US20060211663A1 (en) 2006-09-21
HUP0200416A3 (en) 2004-03-29
CZ20013493A3 (cs) 2002-06-12
HUP0200416A2 (hu) 2002-07-29
US20020165209A1 (en) 2002-11-07
PL202043B1 (pl) 2009-05-29
US7078394B2 (en) 2006-07-18
NZ514463A (en) 2004-01-30
CN1358104A (zh) 2002-07-10
KR20010112386A (ko) 2001-12-20
RU2245713C2 (ru) 2005-02-10
AR029159A1 (es) 2003-06-18
CA2267743C (en) 2011-07-26

Similar Documents

Publication Publication Date Title
ZA200107976B (en) Low dose estrogen interrupted hormone replacement therapy.
HRP20020837A2 (en) Hormone replacement therapy
AU2997500A (en) Single dose delivery device
ZA200109847B (en) 3α-hydroxy-3B methoxymethyl-21-heterocycle substituted steroids with anesthetic activity.
HUP0104901A3 (en) Medicament dispenser
MXPA01011070A (es) Derivados de esteroides.
HUP0200556A3 (en) Medicament for treating diabetes
GB9924780D0 (en) Medicament dispenser
IL157944A0 (en) Hormone replacement therapy
GB2338634B (en) Radiation delivery control
GB9924949D0 (en) Inhaler
GB9930570D0 (en) Therapy
GB2359267B (en) Aroma therapy delivery system
ZA200110046B (en) Therapeutic agents.
MXPA03006157A (es) Metodo de terapia de reemplazo de hormona y su forma de administracion.
AU2223600A (en) Hormone replacement for breast cancer patients
GB9930160D0 (en) Drug delivery
AU5916499A (en) Hormone replacement therapy monitoring
HU0003733D0 (en) Inhaler
ZA200204584B (en) Therapeutic agents.
GB9816436D0 (en) Multiple therapy drug delivery
GB9917737D0 (en) Multiple therapy drug delivery
GB9804768D0 (en) Drug delivery
TW552913U (en) Plate for standing incense thereon
HK1060061A (en) Hormone replacement therapy